Cargando…
COVID-19 Vaccine-Induced Pro-thrombotic Immune Thrombocytopenia (VIPIT): State of the Art
In 2020, as the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) pandemic spread rapidly throughout the world, scientists worked relentlessly to develop and test the safety and effectiveness of potential vaccines. Usually, the vaccine development process involves years of investigat...
Autores principales: | Calcaterra, Giuseppe, Bassareo, Pier Paolo, De Gregorio, Cesare, Barilla, Francesco, Romeo, Francesco, Mehta, Jawahar L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896421/ https://www.ncbi.nlm.nih.gov/pubmed/35319381 http://dx.doi.org/10.2174/1573403X18666220321105909 |
Ejemplares similares
-
The Deadly Quartet (Covid-19, Old Age, Lung Disease, and Heart Failure) Explains Why Coronavirus-Related Mortality in Northern Italy Was So High
por: Calcaterra, Giuseppe, et al.
Publicado: (2021) -
Successful treatment of vaccine‐induced prothrombotic immune thrombocytopenia (VIPIT)
por: Thaler, Johannes, et al.
Publicado: (2021) -
Cerebral venous thrombosis after COVID-19 vaccines: Do we know the mechanism?
por: de Gregorio, Cesare, et al.
Publicado: (2022) -
Letter in response to “COVID‐19, Virchow's triad and thromboembolic risk in obese pregnant women”
por: Calcaterra, Giuseppe, et al.
Publicado: (2021) -
COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis
por: Calcaterra, Giuseppe, et al.
Publicado: (2021)